Thermo Fisher Scientific
NEWS
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 23, 2021.
Cross-continental drug development and commercialization deals are good for business, and imperative for patients to receive access to the most valuable scientific breakthroughs. This month has already brought a number of these partnerships for the treatment of cancer and other diseases. Here’s a look at three of them.
Thermo Fisher Scientific, based in Waltham, Massachusetts, is acquiring Mesa Biotech for about $450 million in cash. There is also an additional $100 million in cash after certain milestones are hit.
Thermo Fisher Scientific announced the completion of Henogen SA, Groupe Novasep SAS’s viral vector manufacturing business in Belgium. The deal was for €725 million in cash.
The company is significantly expanding its footprint with new facilities in the United States and in Europe.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
As of late, the company has already tested almost 15,000 of its 75,000 employees in a pilot program.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020.
The increase reflects the positive financial impact COVID-19 has had on the European diagnostic company’s bottom line.
JOBS
IN THE PRESS